vs
Nextdoor Holdings, Inc.（NXDR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Nextdoor Holdings, Inc.的1.0倍（$69.8M vs $69.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -5.8%，领先389.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 6.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 14.3%）
Nextdoor Holdings, Inc.是一家美国企业，主打面向社区的超本地社交网络服务。公司成立于2008年，总部位于加利福尼亚州旧金山，2011年10月在美国正式推出服务。截至2023年5月，业务已覆盖11个国家，2024年数据显示其平台会员数量达8800万。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NXDR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$69.5M
营收增速更快
RIGL
高出14.7%
6.5%
净利率更高
RIGL
高出389.8%
-5.8%
两年增速更快
RIGL
近两年复合增速
14.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $69.5M | $69.8M |
| 净利润 | $-4.0M | $268.1M |
| 毛利率 | 84.9% | 91.5% |
| 营业利润率 | -10.7% | 33.2% |
| 净利率 | -5.8% | 384.0% |
| 营收同比 | 6.5% | 21.2% |
| 净利润同比 | 66.7% | 1769.2% |
| 每股收益（稀释后） | $-0.01 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NXDRRIGL
| Q4 25 | $69.5M | $69.8M | ||
| Q3 25 | $68.9M | $69.5M | ||
| Q2 25 | $65.1M | $101.7M | ||
| Q1 25 | $54.2M | $53.3M | ||
| Q4 24 | $65.2M | $57.6M | ||
| Q3 24 | $65.6M | $55.3M | ||
| Q2 24 | $63.3M | $36.8M | ||
| Q1 24 | $53.1M | $29.5M |
净利润NXDRRIGL
| Q4 25 | $-4.0M | $268.1M | ||
| Q3 25 | $-12.9M | $27.9M | ||
| Q2 25 | $-15.4M | $59.6M | ||
| Q1 25 | $-22.0M | $11.4M | ||
| Q4 24 | $-12.1M | $14.3M | ||
| Q3 24 | $-14.9M | $12.4M | ||
| Q2 24 | $-42.8M | $-1.0M | ||
| Q1 24 | $-28.3M | $-8.2M |
毛利率NXDRRIGL
| Q4 25 | 84.9% | 91.5% | ||
| Q3 25 | 84.9% | 93.2% | ||
| Q2 25 | 83.6% | 95.6% | ||
| Q1 25 | 82.6% | 91.7% | ||
| Q4 24 | 84.0% | 89.9% | ||
| Q3 24 | 83.0% | 85.5% | ||
| Q2 24 | 83.8% | 92.4% | ||
| Q1 24 | 81.2% | 93.1% |
营业利润率NXDRRIGL
| Q4 25 | -10.7% | 33.2% | ||
| Q3 25 | -25.0% | 40.9% | ||
| Q2 25 | -31.1% | 60.1% | ||
| Q1 25 | -49.9% | 23.9% | ||
| Q4 24 | -26.2% | 28.9% | ||
| Q3 24 | -31.7% | 25.4% | ||
| Q2 24 | -77.4% | 1.2% | ||
| Q1 24 | -65.4% | -23.6% |
净利率NXDRRIGL
| Q4 25 | -5.8% | 384.0% | ||
| Q3 25 | -18.7% | 40.2% | ||
| Q2 25 | -23.6% | 58.6% | ||
| Q1 25 | -40.5% | 21.5% | ||
| Q4 24 | -18.6% | 24.9% | ||
| Q3 24 | -22.7% | 22.5% | ||
| Q2 24 | -67.6% | -2.8% | ||
| Q1 24 | -53.2% | -27.9% |
每股收益（稀释后）NXDRRIGL
| Q4 25 | $-0.01 | $14.11 | ||
| Q3 25 | $-0.03 | $1.46 | ||
| Q2 25 | $-0.04 | $3.28 | ||
| Q1 25 | $-0.06 | $0.63 | ||
| Q4 24 | $-0.03 | $0.82 | ||
| Q3 24 | $-0.04 | $0.70 | ||
| Q2 24 | $-0.11 | $-0.06 | ||
| Q1 24 | $-0.07 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.3M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $431.3M | $391.5M |
| 总资产 | $486.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NXDRRIGL
| Q4 25 | $63.3M | $155.0M | ||
| Q3 25 | $56.1M | $137.1M | ||
| Q2 25 | $62.0M | $108.4M | ||
| Q1 25 | $57.3M | $77.1M | ||
| Q4 24 | $45.5M | $77.3M | ||
| Q3 24 | $49.7M | $61.1M | ||
| Q2 24 | $53.0M | $49.1M | ||
| Q1 24 | $69.7M | $49.5M |
总债务NXDRRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NXDRRIGL
| Q4 25 | $431.3M | $391.5M | ||
| Q3 25 | $429.7M | $117.6M | ||
| Q2 25 | $429.5M | $81.9M | ||
| Q1 25 | $436.1M | $18.6M | ||
| Q4 24 | $453.5M | $3.3M | ||
| Q3 24 | $456.0M | $-14.6M | ||
| Q2 24 | $472.3M | $-29.9M | ||
| Q1 24 | $541.4M | $-31.7M |
总资产NXDRRIGL
| Q4 25 | $486.8M | $513.6M | ||
| Q3 25 | $488.9M | $242.5M | ||
| Q2 25 | $490.4M | $206.7M | ||
| Q1 25 | $495.0M | $176.0M | ||
| Q4 24 | $514.0M | $164.0M | ||
| Q3 24 | $517.7M | $139.4M | ||
| Q2 24 | $542.1M | $128.4M | ||
| Q1 24 | $633.1M | $126.5M |
负债/权益比NXDRRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $9.4M | — |
| 自由现金流率自由现金流/营收 | 13.5% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $5.9M | — |
8季度趋势，按日历期对齐
经营现金流NXDRRIGL
| Q4 25 | $9.5M | $22.0M | ||
| Q3 25 | $-6.3M | $24.0M | ||
| Q2 25 | $2.9M | $30.5M | ||
| Q1 25 | $368.0K | $-893.0K | ||
| Q4 24 | $11.8M | $14.5M | ||
| Q3 24 | $-13.0M | $21.7M | ||
| Q2 24 | $-5.4M | $302.0K | ||
| Q1 24 | $-13.6M | $-5.0M |
自由现金流NXDRRIGL
| Q4 25 | $9.4M | — | ||
| Q3 25 | $-6.5M | — | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | $340.0K | — | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $-13.2M | — | ||
| Q2 24 | $-5.5M | — | ||
| Q1 24 | $-13.6M | — |
自由现金流率NXDRRIGL
| Q4 25 | 13.5% | — | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 17.9% | — | ||
| Q3 24 | -20.1% | — | ||
| Q2 24 | -8.6% | — | ||
| Q1 24 | -25.7% | — |
资本支出强度NXDRRIGL
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.0% | — |
现金转化率NXDRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NXDR
| US | $67.1M | 97% |
| Non Us | $2.3M | 3% |
RIGL
暂无分部数据
